What is BioHarvest Sciences Inc. (CNVCF) stock price today?

BioHarvest Sciences Inc. (CNVCF) is currently trading at $6.30.

What is CNVCF P/E ratio?

BioHarvest Sciences Inc.'s P/E ratio is -7.06. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is CNVCF return on equity (ROE)?

BioHarvest Sciences Inc.'s return on equity (ROE) is 190.98%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.

What is BioHarvest Sciences Inc.'s market cap?

BioHarvest Sciences Inc. has a market capitalization of $109.16M.

OTC · Drug Manufacturers - Specialty & Generic

BioHarvest Sciences Inc. (CNVCF) Stock

$6.30 OTC: CNVCF Healthcare

Valuation

Metric	Value
Price	$6.30
Market Cap	$109.16M
P/E Ratio	-7.06
P/B Ratio	68.81
P/S Ratio	3.89
EPS (TTM)	$-0.93
52-Week High	$6.30
52-Week Low	$6.30
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	190.98%
ROA	-51.65%
ROCE	-65.06%
Gross Margin	55.35%
Operating Margin	-27.75%
Net Margin	-51.27%
Debt/Equity	10.39
Current Ratio	0.55

Annual Financials (USD)

Metric	2019	2020	2021	2022	2023
Revenue	$0	$0	$2.0M	$5.0M	$13.0M
Operating Profit	$-2.0M	$-6.0M	$-8.0M	$-11.0M	$-10.0M
Net Profit	$-5.0M	$-7.0M	$-10.0M	$-11.0M	$-13.0M
EPS	$-1.80	$-0.68	$-0.79	$-0.86	$-0.93
Op Margin	-1059.6%	-1557.1%	-403.9%	-193.0%	-78.7%

Balance Sheet (USD)

Metric	2019	2020	2021	2022	2023
Total Assets	$2.0M	$5.0M	$10.0M	$9.0M	$15.0M
Total Liabilities	$29.0M	$8.0M	$7.0M	$15.0M	$30.0M
Cash	$1.0M	$2.0M	$4.0M	$2.0M	$5.0M
Borrowings	$24.0M	$3.0M	$2.0M	$11.0M	$22.0M

Latest News

Hyundai Motor reports 21% drop in Q2 operating profit, misses forecasts Reuters · Jul 23, 2026 Asian stocks rise as AI capex ramps up, oil at six-week highs Reuters · Jul 23, 2026 TenPay Global Named to CNBC's World's Top Fintech Companies 2026 List PR Newswire · Jul 23, 2026 Besi posts sharp rise in quarterly orders Reuters · Jul 23, 2026 Nokia provides recast comparative financial information reflecting the presentation of Fixed Wireless Access CPE and Enterprise Campus Edge businesses as discontinued operations GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric	2019	2020	2021	2022	2023
Operating Cash Flow	$-2.0M	$-4.0M	$-7.0M	$-9.0M	$-9.0M
Investing Cash Flow	$0	$0	$-3.0M	$-3.0M	$-3.0M
Financing Cash Flow	$2.0M	$0	$4.0M	$1.0M	$0
Net Cash Flow	$0	$1.0M	$2.0M	$-2.0M	$4.0M
Free Cash Flow	$-2.0M	$-4.0M	$-8.0M	$-10.0M	$-10.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.36
EV / EBITDA	-15.81
FCF Yield	-9.72%
Quick Ratio	0.29
Interest Coverage	-1.48
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ADOIFAdocia S.A.	$8.87	+0.00%	-2.46	$103.66M	0.00%
AMEUFAnteris Technologies Ltd	$5.70	-35.81%	-3.37	$120.50M	0.00%
COPHFCreso Pharma Limited	$0.12	+0.00%	-0.40	$131.72M	0.00%
CSAMFCSAM Health Group AS	$4.82	+0.00%	-21.09	$98.80M	1.27%
EOFBYEcofibre Limited	$0.84	+0.00%	-0.17	$73.67M	0.00%

About BioHarvest Sciences Inc.

BioHarvest Sciences Inc., along with its subsidiaries, supplies a range of nutraceutical products and medical cannabis to customers both in Israel and globally. The company leverages an innovative plant cell growth technology that allows it to cultivate active secondary metabolites directly from cells, completely circumventing the need to grow the actual plant. BioHarvest is responsible for the entire process, from designing and developing to manufacturing and marketing its offerings. These include Vinia, a nutraceutical powder derived from red grapes, as well as its medical cannabis line. The firm's main operational base is located in Vancouver, Canada.

BioHarvest Sciences Inc. is headquartered in CA.

BioHarvest Sciences Inc. (CNVCF) stock trades at $6.30 with a market capitalization of $109.16M. The stock is valued at a negative price-to-earnings (P/E) ratio of -7.06, reflecting a net loss over the last twelve months, price-to-book of 68.81, price-to-sales of 3.89. Over the past 52 weeks the stock has ranged between $6.30 and $6.30, and currently trades at or near its 52-week high.

On profitability, BioHarvest Sciences Inc. generates a return on equity (ROE) of 190.98%, above the typical market range of roughly 12-15%, return on capital employed of -65.06%, an operating margin of -27.75%, a net profit margin of -51.27%.

Official website: www.bioharvest.com